FDA Says Weight Loss Drug Lorcaserin May Increase Risk of Cancer

The FDA has issued a safety alert for the weight management medicine Belviq, Belviq XR (lorcaserin) due to a possible increased risk of cancer with …

| | | |

FDA Investigates Diabetes Drug, Metformin for Possible Impurities

The Food and Drug Administration (FDA) is investigating whether metformin sold in the U.S. contains a possible carcinogen. The U.S. Food and Drug …


Swiss Drugmaker Halts Distribution of Zantac Worldwide

Novartis AG’s Sandoz unit, the maker of ranitidine, or Zantac, a popular heartburn medication announced today it would halt global …


Vivimed Voluntarily Recalls Losartan Potassium Tablets due to Impurity

Vivimed Life Sciences is recalling 19 lots of Losartan Potassium Tablets USP 25 mg, 50 mg, and 100 mg due to the detection of an impurity that is …


Teva Recalls Blood Pressure Medication in the U.S.; Adds to Growing List

Teva Pharmaceutical Industries announced this week it is voluntarily recalling some of its blood pressure drugs in the U.S. due to an impurity in …


FDA Issues Voluntary Recall of Blood Pressure Medication Due to Cancer Concerns

A voluntary recall of a blood pressure medication due to impurities, which may lead to a cancer risk, was recently issued by Sandoz Inc. The company …

| |